NP47827 Multiple Sclerosis Medicines
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Scope as published
The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine
- Deadline
- Not published
- Published
- 26 Oct 2026(5 hours ago)
- Contract value
- £30.4m
- Location
- United Kingdom
- Reference
ocds-h6vhtk-079097- First seen
- 1 hour ago